STAT+: RNA firm GreenLight Biosciences to go public in $1.2 billion deal
A Massachusetts-based synthetic biology company whose research ranges from developing pesticide alternatives for crops to…
Category: Biotech
Opinion: Listen: Two physicians, one of whom had a ‘breakthrough infection,’ on Covid-19 among the vaccinated
In this week’s episode of the “First Opinion Podcast,” psychiatrist Stephen Tourjee shares his experience…
Opinion: Harm-reduction programs acknowledge the difference between ‘do no harm’ and ‘protect from harm’
Brian, a patient at my clinic in Scott County, Ind., is one of many who…
Opinion: Algorithmic bias is pervasive in health care. It needn’t be
The World Health Organization issued its first global report on artificial intelligence in late June,…
A WHO official on why we need a global tech strategy to fight vaccine misinformation
The creation of effective vaccines has offered a lifeline in the worst pandemic in world…
STAT+: As tech giants double down on sleep tracking, providers want more proof it’s useful
Wearable sleep tracking has been an alluring target for tech giants for nearly a decade….
.jpg)
STAT+: ‘We don’t unlearn’: What the pandemic has taught regulators about real-world data
During the pandemic, regulatory agencies deployed emergency measures left and right to speed care to…
STAT+: ‘Things are so messed up’: Patient access to antibiotics is lacking even in the wealthiest countries
Although 18 innovative antibiotics were approved by regulators in the wealthiest nations over the past…
A ‘frothy’ digital health market, Verily partners with Colgate, & a HIMSS dispatch
You’re reading the web edition of STAT Health Tech, our guide to how tech is…
STAT+: STAT+ Conversation: Blueprint for cancer drugs
Editor’s note: A livestream of the conversation will be embedded below at 1 p.m. ET….
STAT+: Pharmalittle: Bluebird to wind down European operations over pricing; whither the FDA’s accelerated approval pathway?
Good morning, everyone, and how are you today? The sun is trying to peek through…
Opinion: Digital twins: Will doubling up help personalize health care?
Two often-cited emerging trends in the health care space are personalized care and remote care….
Opinion: Ridesharing can help older people be functionally independent in their homes, communities
The United States has experienced a particularly rapid period of expansion of the older adult…
Opinion: Don’t let children under 12 slip through the cracks in the fight against Covid
“Vaxxed and waxed” may be the TikTok sensation of the moment, a rallying cry for…
.jpg)
STAT+: Will controversy over new Alzheimer’s drug spell the end for the FDA’s faster approval process?
WASHINGTON — For most of its history, the Food and Drug Administration’s shortcut pathway for…
A snort or a jab? Scientist debate potential benefits of intranasal Covid-19 vaccines
As the world amasses experience with Covid-19 vaccines, something we should have known from the…
STAT+: After leaving patients in limbo, Pfizer agrees to sell a discontinued glaucoma drug
After months of controversy, Pfizer (PFE) has reached a deal to sell a decades-old eye…
STAT+: Pharmalittle: Still no word from Biden on a new FDA chief; CMS pulls ‘most favored nation’ rule for lowering drug prices
Good morning, everyone, and welcome to another working week. We hope the weekend respite —…
STAT+: As White House mulls FDA commissioner job, a sign of industry backing for Woodcock surfaces
Shortly after the Biden administration took office, a letter-writing campaign erupted over who should be…
Opinion: STAT+: Viruses, variants, and the business of health care: Preparing for another wave now and the years ahead
We’re in a new phase of the Covid-19 pandemic in which new mutations will have…
Opinion: Applying a pandemic-like response to cancer prevention
In 2020, a year of unimaginable tragedy, an estimated 375,000 people died from Covid-19 infections…
STAT+: In the feeding frenzy of health tech dealmaking, the little fish wield power
The fickle market only lets executives at health care startups control so much, but for…
A WHO expert explains why she believes the rush for Covid-19 boosters is premature
When the World Health Organization last week called for a moratorium on giving Covid-19 booster…
STAT+: Adagio raises $300 million in IPO, looks to advance Covid-19 antibody therapy
Adagio Therapeutics, a Waltham startup advancing COVID-19 antibody treatments, is going public Friday just over…
As HIMSS approaches, plans for health tech’s biggest gathering are clashing with a need for caution
It was supposed to be a coming out party for the digital health industry after…
STAT+: Pharmalittle: FDA expects to have Covid booster plan by early September; feds halt Novavax vaccine funding
Wakey-wakey, everyone. It’s Friday! You can sip your cup of stimulation with satisfaction this morning:…
Opinion: Responsible AI: leveraging data and technology to counteract bias
Left unchecked, algorithmic approaches can perpetuate bias in health care. Implementing responsible AI can help…
Opinion: Making hearing aids affordable isn’t enough. Older adults also need hearing care services
When Anne Madison noticed her hearing was declining at age 66, she struggled. She had…
Desperate for relief amid Covid-19, hospitals find an unusual ally in Susan Collins
WASHINGTON — The lobbying frenzy began late last month, as senators and the White House…
STAT+: A federal appeals court throws into question the fate of ‘skinny labels’ — and access to generic drugs
In a decision with enormous implications for the U.S. health care system, a federal appeals…
Listen: The mRNA gold rush, Delta’s alarming rise, & the next treatment for Alzheimer’s
Who’s going to win the mRNA bake-off? How worrisome is the Delta variant? And why…
STAT+: Scientists plumbing mysterious RNAs in the human genome find a possible treatment for an inherited disorder
When hundreds of scientists from around the world finally pieced together a draft of the…
STAT+: U.K. antitrust watchdog issues a provisional ruling that Pfizer engaged in price gouging
After being forced to reassess its original findings, a U.K. antitrust watchdog has issued a…
Opinion: With the tobacco settlement, the U.S. missed its moment to fortify public health. We can’t make that mistake with the opioid settlement
States, counties, cities, and tribes have brought thousands of lawsuits seeking to hold players in…
STAT+: Pharmalittle: HHS watchdog to review FDA approval of Alzheimer’s drug; Moderna sold $4.2 billion of its Covid-19 vaccine
Good morning, everyone, and how are you today? We are doing just fine, thank you….
Radiology software company Sirona Medical emerges from stealth mode
You’re reading the web edition of STAT Health Tech, our guide to how tech is…
Isabella Cueto named the first Sharon Begley-STAT Science Reporting fellow
The first recipient of the Sharon Begley-STAT Science Reporting Fellowship is Isabella Cueto, a Cuban…
Opinion: STAT+: Human-centered design can boost clinical trial recruitment, retention
By disrupting the clinical trials process, the Covid-19 pandemic has served as a tipping point…
Opinion: The ethical implications of who judges what’s ‘necessary’ when it comes to emergency care
Last month, I rushed to a nearby hospital for emergency care after experiencing pelvic pain…
Billions in new research funding sparks a lobbying frenzy among patient advocates
WASHINGTON — President Biden’s vision for an ambitious new government research center is never quite…
STAT+: Athira cited altered studies in $15 million NIH grant application, creating legal risk
Biotech company Athira Pharma, which is in turmoil after its chief executive was found to…
With a nudge from AI, ketamine emerges as a potential rare disease treatment
In the seven difficult years since their son Mateo was diagnosed with a rare disease,…
STAT+: Bayer inks a $1.5 billion deal for a biotech with a proprietary drug discovery platform
In a bid to quickly broaden its drug discovery abilities, Bayer (BAYRY) has reached a…
STAT+: Federal watchdog will review the controversial FDA approval of Biogen’s Alzheimer’s drug
The federal watchdog at the Department of Health and Human Services will review the process…
STAT+: Canadian agency loses a battle in effort to force a drug maker to lower ‘excessive’ pricing
In a withering ruling, a Canadian appeals court overturned a controversial decision issued four years…
Artificial pancreases were a breakthrough for type 1 diabetes. The research in type 2 is just beginning
For the first time, a team of researchers has published research into how a closed-loop…
Large study finds genetic signals that might be used to predict early menopause
A large new study scanned the genes of hundreds of thousands of women near the…
WHO calls for a temporary moratorium on administering booster shots of Covid-19 vaccines
The World Health Organization called Wednesday for a temporary moratorium on the use of Covid-19…
STAT+: Pharmalittle: FDA aims to fully approve Pfizer Covid-19 vaccine by Labor Day; SoftBank grabs $5 billion stake in Roche
Rise and shine, everyone, the middle of the week is already here. Congratulations on making…
Opinion: Listen: A longtime glioblastoma survivor on how to keep surviving
In this week’s episode of the “First Opinion Podcast,” writer and philosopher Adam Hayden opens…